Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
The Vita GroupCommercial Finance Director | BU FD
Feb. 2025London Area, United Kingdom
GlaxoSmithKlineCommercial and Medical Digital and Tech Finance Director
May. 2022 - Feb. 2025London, United KingdomI oversee the financial management for Global Commercial and Medical Digital & Tech, managing a £150 million budget. My focus is on strategic investment allocation, especially in digital and data-driven analytics, to support omnichannel strategies and AI initiatives. I lead digital transformation projects that enable product launches and ensure ROI. I also develop business cases and advocate for investments in Global Opex ROI AI initiatives to enhance financial performance. Key Achievements: • Achieved a 12% cost saving by transforming the Commercial Tech operating model, reallocating these savings to develop new capabilities. • Secured corporate funding for advancing data-driven analytics, omnichannel strategies, and generative AI projects, supporting strategic investment decisions. • Finance leadership to digital content optimization strategy that delivered a 15% budget saving and maximized the use of a global content provider, reducing dependency on agencies. • Developed a business case that led to investment in Global Opex ROI AI, improving the company’s financial insight and decision-making capabilities.
GlaxoSmithKlineConsumer Healthcare Export Finance Director
Nov. 2018 - Mar. 2022London, United KingdomI led financial strategies to optimize the operating model and strategy for global export markets, managing £500 million in revenue. By streamlining operations from 14 export hubs down to 5, I achieved substantial savings in operational expenditure. I strategically allocated resources to maximize profitability, resulting in a 10% improvement in operating profit. I also consolidated distributor partners and exited non-profitable markets to enhance efficiency and focus. Key Achievements: • Managed finance operations for the Middle East and Africa export markets, overseeing a £200 million business with substantial year-on-year growth, and achieved a 10% increase in operating profit by reallocating resources based on market profitability. This transformation also involved consolidating distributor partners and exiting non-profitable markets to enhance focus and efficiency. • Played a pivotal role in the GSK-Pfizer joint venture by defining a unified export model and seamlessly integrating a £40 million Pfizer export business, enhancing overall financial performance and aligning operations under a single strategy. • Spearheaded the Consumer Healthcare Export Finance Transformation, transitioning to a centralized Finance Hub, which improved financial management and reporting. This transformation also delivered £3 million in operational expenditure savings by reducing the number of export hubs from 14 to 5. • Led the implementation of a single instance ERP system across the global Consumer Healthcare Export division, ensuring cohesive and streamlined financial processes that unified the business’s financial operations and reporting mechanisms. • Consolidated export hubs and optimized the operating model, resulting in £3 million in operational expenditure savings and a unified approach that maximized efficiency across the global export division.
GlaxoSmithKlineCommercial Finance Director
Aug. 2015 - Nov. 2018London, United KingdomI directed the financial strategy for the Global franchise, focusing on product strategies for Benlysta (SLE) and Daprodustat (renal anemia). I collaborated with key markets to enhance Benlysta's commercial performance, achieving an impressive 20% year-over-year growth by setting ambitious franchise plans, targets, and forecasts. I also led the financial oversight for the launch of Benlysta’s new subcutaneous formulation, which generated £60 million in sales within the first year. For Daprodustat, I managed the financial aspects of its clinical development, working closely with the clinical team to evaluate development options and implement a £300 million clinical program change, mitigating risks and increasing the probability of success. Additionally, I managed the Global Franchise budget of £10 million, strategically prioritizing investments to strengthen early and late-stage franchise assets. Key Achievements: • Orchestrated the launch of Benlysta’s new formulation, driving 20% growth for the franchise and generating £60 million in first-year sales. • Implemented a re-design of the product development program, optimizing clinical strategies and increasing the risk-adjusted net present value by approximately £100 million. • Led a decision tree option analysis that enabled efficient allocation of the £300 million clinical program budget, enhancing program success. • Developed a strategic financial model to support investment decisions, streamlining and improving the budget prioritization process for greater impact. • Built strong partnerships with key market stakeholders, ensuring alignment with global franchise objectives and financial targets.
GlaxoSmithKlineFinance Director
Jan. 2014 - Aug. 2015Prague, Czech RepublicI led financial operations and strategic decision-making for the Pharma division in the Czech Republic, managing £70 million in revenue and £42 million in operating profit. I worked closely with the General Manager and therapy area leaders to develop long-term strategic plans and directed performance management across the region, ensuring a consistent flow of financial data and conducting customer profitability reviews to guide pricing strategies. Additionally, I managed the local finance team, focusing on talent management, leadership development, and personnel growth within the country. Key Achievements: • Achieved 7% market growth despite facing the challenge of generic entries for a major product. • Secured a 70% market share for a leading vaccine product, even with new competitor challenges. • Improved financial reporting accuracy and guided strategic pricing decisions through detailed customer profitability analyses. • Fostered professional growth within the finance team, enhancing skills and strengthening the department’s expertise. • Collaborated with cross-functional teams to develop and execute strategic plans aligned with corporate objectives.
GlaxoSmithKlineAudit Manager
Jan. 2012 - Dec. 2013London, United KingdomI led comprehensive commercial and financial audits across various units within a leading healthcare organization, including Pharma, Consumer Healthcare, finance shared services, Corporate Treasury, and outsourcing operations. I reported audit findings and strategic recommendations directly to the Corporate Audit and Risk Committee. I also delivered essential Risks and Controls Basics training to enhance the financial acumen and compliance awareness of the Finance organization. My role involved developing and implementing audit strategies to identify and mitigate risks, ensuring alignment with global regulatory standards and best practices. I coordinated cross-functional teams to conduct thorough and efficient audit processes. Key Achievements: • Strengthened risk management by identifying key areas for improvement and implementing strategic recommendations, enhancing the organization’s risk profile. • Enhanced the Finance team’s skills and compliance awareness through comprehensive Risks and Controls Basics training. • Streamlined audit processes, leading to more efficient and effective audit cycles and improved outcomes. • Fostered a culture of compliance and risk awareness within the Finance organization, supporting adherence to global standards. • Contributed to the organization’s reputation for integrity and accountability through meticulous and transparent audit practices.
InchcapeGroup Internal Auditor
Mar. 2008 - Jan. 2012London, United KingdomI conducted comprehensive internal audits and business process reviews, identifying opportunities to enhance financial and operational controls. I advised on SAP implementation to optimize and streamline business unit operations and played a key role on the integration team to ensure the seamless assimilation of newly acquired businesses in line with corporate standards and strategic objectives. Additionally, I developed and implemented robust auditing protocols to mitigate risks and improve compliance across various departments. Key Achievements: • Identified and recommended critical improvements in financial and operational controls, which were adopted by senior management, leading to enhanced company-wide efficiency. • Provided essential guidance on SAP implementation, resulting in more streamlined and efficient operations across business units. • Actively participated in the integration of newly acquired businesses, ensuring a smooth transition and alignment with the company’s strategic objectives. • Developed and instituted comprehensive auditing protocols, significantly mitigating risks and improving compliance levels. • Facilitated a more efficient and cohesive auditing process, contributing to the company's overall operational effectiveness.
PricewaterhouseCoopers, LondonAudit Assistant Manager/Executive, Assurance and Advisory
Oct. 2002 - Feb. 2008Strong audit background in and business knowledge of both mature (UK) and fast-paced emerging (Ukraine and Russia) markets Strong technical IFRS knowledge Managed audit teams and acted as an audit project manager with a proven track of delivery within tight deadlines Prepared in-depth financial analysis of the audit clients’ accounts (mainly trend and ratio analysis) Strong communication and presentation skills: presented audit findings and advice on complex accounting issues to the clients
Intch is a Professional Networking App for the Future of WorkSee more people like Eugene on Intch
300k+ people
130+ countries
AI matching
Get Intch if you'd like to
740615 people
21
HR @ Binance
16
Executive Assistant
29
Government /Business /Investors Relations @ The Business Year
82722 people
27
Partner @ Kpmg
16
CFO @ British tourism authority
17
Finance Director